701P NCI10221: Phase II multicenter biomarker driven combination trial of copanlisib and nivolumab in patients with molecularly-selected advanced solid tumors (BaCoN)
Yap, T.A., Piha-Paul, S.A., Karp, D., Dumbrava, E.E., Hong, D.S., Fu, S., Subbiah, V., Tsimberidou, A.M., Rodon, J., Rhudy, J., Valladolid, C., Yuan, Y., Jana, B., Spiliopoulou, P., Randall, L., Poklepovic, A., Sehgal, K., Shapiro, G.I., Said, R., Meric-Bernstam, F.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
248TiP A randomized, double-blind, phase III trial of neoadjuvant chemotherapy (NACT) with atezolizumab/placebo in patients (pts) with triple-negative breast cancer (TNBC) followed by adjuvant continuation of atezolizumab/placebo (GeparDouze)
Loibl, S., Rastogi, P., Seiler, S., Jackisch, C., Lucas, P.C., Denkert, C., Poklepovic, A., Moreno, F., Mamounas, E.P., Nekljudova, V., Lin, Y., Wolmark, N., Geyer, C.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
Retrospective health care claims database analysis of direct medical costs of newly diagnosed patients (pts) with hepatocellular carcinoma (HCC) in the United States
Poklepovic, A. S., Sanyal, A., Moyneur, E., Meyers, S., Barghout, V.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
Insulin Activates Protein Kinases C-ζ and C-λ by an Autophosphorylation-dependent Mechanism and Stimulates Their Translocation to GLUT4 Vesicles and Other Membrane Fractions in Rat Adipocytes
Standaert, Mary L., Bandyopadhyay, Gautam, Perez, Liliam, Price, Debbie, Galloway, Lamar, Poklepovic, Andrew, Sajan, Minni P., Cenni, Vitorria, Sirri, Alessandra, Moscat, Jorge, Toker, Alex, Farese, Robert V.
Published in The Journal of biological chemistry (03.09.1999)
Published in The Journal of biological chemistry (03.09.1999)
Get full text
Journal Article